Clinical Trial Update: CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation [Phase 4]

View source ↗

Summary

The CACAF2 study evaluating catheter ablation for cure of atrial fibrillation in Phase 4 was terminated, with results posted in January 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Biosense Webster EMEA | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED | Results posted: 2015-01-14